Related references
Note: Only part of the references are listed.Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
A global survey of potential acceptance of a COVID-19 vaccine
Jeffrey V. Lazarus et al.
NATURE MEDICINE (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang et al.
LANCET INFECTIOUS DISEASES (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy
Lorenzo Palamenghi et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
CONCERNS INTENSIFY OVER UPCOMING COVID-VACCINE RESULTS
Smriti Mallapaty et al.
NATURE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil
Renato Luiz Marchetti et al.
VACCINE (2020)
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Jiahao Wang et al.
VACCINES (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
COVID-19 Public needs to prep for vaccine side effects
Meredith Wadman
SCIENCE (2020)
The MMR Vaccine and Autism
Frank DeStefano et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review
Maoqiang Tian et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Causal relationship between immunological responses and adverse reactions following vaccination
Tetsuo Nakayama
VACCINE (2019)
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Zhiqi Song et al.
VIRUSES-BASEL (2019)
Vaccines and multiple sclerosis: a systematic review
Mia Topsoe Mailand et al.
JOURNAL OF NEUROLOGY (2017)
Recent advances in the production of recombinant subunit vaccines in Pichia pastoris
Man Wang et al.
BIOENGINEERED (2016)
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Nikolai Madrid Scheller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2015)
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Ana Maria Henao-Restrepo et al.
LANCET (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Alberta Di Pasquale et al.
VACCINES (2015)
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Dimitrios Karussis et al.
AUTOIMMUNITY REVIEWS (2014)
Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants
S. Sohail Ahmed et al.
JOURNAL OF AUTOIMMUNITY (2014)
Epilepsy and vaccinations: Italian guidelines
Dario Pruna et al.
EPILEPSIA (2013)
Mass psychogenic illness and the social network: is it changing the pattern of outbreaks?
Robert E. Bartholomew et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2012)
Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
Jenny M. Reimer et al.
PLOS ONE (2012)
Vaccines and Guillain-Barre Syndrome
Penina Haber et al.
DRUG SAFETY (2009)
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
Yann Mikaeloff et al.
NEUROLOGY (2009)
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
Ann W. McMahon et al.
VACCINE (2007)
Guillain-Barre syndrome following influenza vaccination
P Haber et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Lack of evidence of encephalopathy related to pertussis vaccine: Active surveillance by IMPACT, Canada, 1993-2002
DL Moore et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Vaccinations and risk of central nervous system demyelinating diseases in adults
F DeStefano et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
